James F. Young, an insider at Novavax, has planned to sell a total of 10,000 shares of common stock in two transactions. The first sale of 4,600 shares is scheduled for 12/24/2024 at $8.48 per share, followed by a second sale of 5,400 shares on 12/31/2024 at $8.00 per share.The total market value of the disposed shares amounts to $82,208. After these transactions, Young's remaining direct ownership in Novavax will be 51,760 shares. Both sales are classified as open market or private sales.These planned transactions indicate a reduction in Young's stake in Novavax, with the sales occurring at slightly different price points over a week-long period. The company has not provided any additional context for these insider sales.

James F. Young, an insider at Novavax, has planned to sell a total of 10,000 shares of common stock in two transactions. The first sale of 4,600 shares is scheduled for 12/24/2024 at $8.48 per share, followed by a second sale of 5,400 shares on 12/31/2024 at $8.00 per share.The total market value of the disposed shares amounts to $82,208. After these transactions, Young's remaining direct ownership in Novavax will be 51,760 shares. Both sales are classified as open market or private sales.These planned transactions indicate a reduction in Young's stake in Novavax, with the sales occurring at slightly different price points over a week-long period. The company has not provided any additional context for these insider sales.